Rice-Made blood protein under Real-World watch for emergency patients
NCT ID NCT07435922
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow about 2,000 patients who need urgent treatment for low blood protein (hypoalbuminemia) or low blood volume (hypovolemia) and are receiving a plant-based human albumin. Researchers will track side effects and how well the treatment restores albumin levels and blood volume. The goal is to gather real-world safety and effectiveness data, not to test a new drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOALBUMINEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hebei medical university third hosipital
Shijiazhuang, Hebei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••